Explicyte Immuno-Oncology - Cancer Immunotherapy CRO Services
Cancer Immunotherapy CRO Services
Discovery
Custom biospecimen sourcing
Target identification
Target expression profiling
Preclinical
Tumor killing
Tumor sensitization
Activation & immune checkpoint inhibition
Antibody-dependent cell cytotoxicity (ADCC)
Tumor antigen-specific killing
Bispecific T cell engager (BiTE) killing
Antibody-Drug Conjugate (ADC) killing
Immuno-modulation
Immune cell activation
Immune cell migration
Mixed lymphocyte reaction (MLR)
Macrophage assays
TLS-GC reaction
Cytokine release syndrome
Featured
Xenium for cells
Trials
Services
Biomarker discovery
TLS detection & evaluation
Image analysis
Platforms
Spatial Biology
Single-cell spatial transcriptomics
Digital spatial profiling
Visium HD: Whole-Transcriptome Spatial Biology
Quantitative digital pathology
Multi-Omics
Single-cell RNA Seq
Proteomics
Flow cytometry
About
About Explicyte
Science
News
Careers
Contact us
Toggle menu
Contact us
Posts classified under:
Oncology Target & Biomarker Discovery
Explicyte Immuno-Oncology
>
CRO Services
>
Oncology Target & Biomarker Discovery
View Details
Oncology Target Identification Services Using FFPE Transcriptomics
View Details
Oncology Target Expression Profiling in FFPE Tissues
View Details
Target identification & validation for cancer immunotherapies
WordPress Lightbox
